Package 72162-1237-1

Brand: chlordiazepoxide hydrochloride and clidinium bromide

Generic: chlordiazepoxide hydrochloride and clidinium bromide
NDC Package

Package Facts

Identity

Package NDC 72162-1237-1
Digits Only 7216212371
Product NDC 72162-1237
Description

100 CAPSULE in 1 BOTTLE (72162-1237-1)

Marketing

Marketing Status
Marketed Since 2023-12-05
Brand chlordiazepoxide hydrochloride and clidinium bromide
Generic chlordiazepoxide hydrochloride and clidinium bromide
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "f117d27f-d753-446f-a7f3-a180fe42233f", "openfda": {"unii": ["MFM6K1XWDK", "91ZQW5JF1Z"], "rxcui": ["889614"], "spl_set_id": ["160c6524-314f-404a-ac04-0f3bfae2fde3"], "manufacturer_name": ["Bryant Ranch Prepack"]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE in 1 BOTTLE (72162-1237-1)", "package_ndc": "72162-1237-1", "marketing_start_date": "20231205"}], "brand_name": "Chlordiazepoxide Hydrochloride and Clidinium Bromide", "product_id": "72162-1237_f117d27f-d753-446f-a7f3-a180fe42233f", "dosage_form": "CAPSULE", "pharm_class": ["Anticholinergic [EPC]", "Benzodiazepine [EPC]", "Benzodiazepines [CS]", "Cholinergic Antagonists [MoA]", "Decreased Parasympathetic Acetylcholine Activity [PE]", "Digestive/GI System Activity Alteration [PE]", "GI Motility Alteration [PE]"], "product_ndc": "72162-1237", "dea_schedule": "CIV", "generic_name": "Chlordiazepoxide Hydrochloride and Clidinium Bromide", "labeler_name": "Bryant Ranch Prepack", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Chlordiazepoxide Hydrochloride and Clidinium Bromide", "active_ingredients": [{"name": "CHLORDIAZEPOXIDE HYDROCHLORIDE", "strength": "5 mg/1"}, {"name": "CLIDINIUM BROMIDE", "strength": "2.5 mg/1"}], "application_number": "ANDA211421", "marketing_category": "ANDA", "marketing_start_date": "20200709", "listing_expiration_date": "20261231"}